CLINICAL TRIALS PROFILE FOR NORCURON
✉ Email this page to a colleague
All Clinical Trials for NORCURON
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00970762 ↗ | Comparative Study of Rocuronium With Vecuronium (Study 71101)(COMPLETED) | Completed | Merck Sharp & Dohme Corp. | Phase 3 | 2003-02-01 | This study was conducted to determine and compare the safety and effectiveness of two neuromuscular blockers (rocuronium and vecuronium) at various doses in adults who are undergoing general elective surgery with sevoflurane anesthesia. Study participants received an intubating dose of a neuromuscular blocker (to enable insertion of a tube through the nose or mouth into the trachea to provide artificial ventilation). The intubating dose was followed by repeated bolus maintenance doses as needed, to maintain muscle relaxation. The time it takes to reach maximal effect of the neuromuscular blocker (onset time) after the intubating dose was measured and compared as the primary outcome. |
| NCT01690338 ↗ | A Study of Residual Curarization Incidence in China | Unknown status | Central South University | Phase 4 | 2012-10-01 | The purpose of this study is to determine the incidence of residual curarization in PACU and relevant risk factors. |
| NCT01690338 ↗ | A Study of Residual Curarization Incidence in China | Unknown status | China Medical University Hospital | Phase 4 | 2012-10-01 | The purpose of this study is to determine the incidence of residual curarization in PACU and relevant risk factors. |
| NCT01690338 ↗ | A Study of Residual Curarization Incidence in China | Unknown status | Chinese PLA General Hospital | Phase 4 | 2012-10-01 | The purpose of this study is to determine the incidence of residual curarization in PACU and relevant risk factors. |
| NCT01690338 ↗ | A Study of Residual Curarization Incidence in China | Unknown status | Eastern Hepatobiliary Surgery Hospital | Phase 4 | 2012-10-01 | The purpose of this study is to determine the incidence of residual curarization in PACU and relevant risk factors. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for NORCURON
Condition Name
Clinical Trial Locations for NORCURON
Clinical Trial Progress for NORCURON
Clinical Trial Phase
Clinical Trial Sponsors for NORCURON
Sponsor Name
| Sponsor Name for NORCURON | |
| Sponsor | Trials |
| First Affiliated Hospital of Xinjiang Medical University | 1 |
| The First Teaching Hospital of Xinjiang Medical University | 1 |
| First Affiliated Hospital of Zhejiang University | 1 |
| [disabled in preview] | 2 |
| This preview shows a limited data set Subscribe for full access, or try a Trial | |
